Department of Internal Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
J Am Coll Cardiol. 2013 Aug 20;62(8):752-60. doi: 10.1016/j.jacc.2013.03.038. Epub 2013 Apr 16.
The goal of this study was to investigate the association between natriuretic peptides and body fat distribution in a multiethnic cohort.
Natriuretic peptides stimulate lipolysis, reduce weight gain, and promote adipocyte browning in animal models, but data are lacking in humans.
A total of 2,619 participants without heart failure in the Dallas Heart Study underwent measurements of 1) B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP); and 2) body fat distribution by dual energy x-ray absorptiometry and magnetic resonance imaging. Cross-sectional associations of natriuretic peptides with adiposity phenotypes were examined after adjustment for age, sex, race, comorbidities, and body mass index.
Median BNP and NT-proBNP levels in the study cohort (mean age 44 years; 56% women, 48% African Americans, 32% obese) were 3.0 and 28.1 pg/ml, respectively. Natriuretic peptide levels above the median were associated with a more favorable body fat profile and less insulin resistance, including lower visceral fat, liver fat, and homeostasis model assessment of insulin resistance index, and increased lower body fat and higher adiponectin (p < 0.05 for each). In multivariable analyses, NT-proBNP remained inversely associated with visceral fat (beta coefficient = -0.08; p < 0.0001) and liver fat (beta coefficient = -0.14; p < 0.0001) and positively associated with lower body fat (beta coefficient = 0.07; p < 0.0001) independent of age, sex, race, and obesity status; findings were similar with BNP. Adjustment for body composition, homeostasis model assessment of insulin resistance index, circulating androgens, and adipocytokines did not attenuate the associations.
Higher natriuretic peptide levels were independently associated with a favorable adiposity profile, characterized by decreased visceral and liver fat and increased lower body fat, suggesting a link between the heart and adipose tissue distribution mediated through natriuretic peptides.
本研究旨在探讨利钠肽与多民族队列中体脂分布的关系。
利钠肽在动物模型中刺激脂肪分解、减少体重增加并促进脂肪细胞褐变,但在人体中数据缺乏。
达拉斯心脏研究中共有 2619 名无心力衰竭的参与者接受了 1)B 型利钠肽(BNP)和 N 末端 pro-B 型利钠肽(NT-proBNP)的测量;2)通过双能 X 射线吸收法和磁共振成像测量体脂分布。在调整年龄、性别、种族、合并症和体重指数后,检查利钠肽与肥胖表型的横断面关联。
研究队列中 BNP 和 NT-proBNP 的中位数水平(平均年龄 44 岁;56%为女性,48%为非裔美国人,32%为肥胖)分别为 3.0 和 28.1 pg/ml。利钠肽水平高于中位数与更有利的体脂分布和更低的胰岛素抵抗相关,包括更低的内脏脂肪、肝脏脂肪和稳态模型评估的胰岛素抵抗指数,以及更高的下半身脂肪和更高的脂联素(p<0.05)。在多变量分析中,NT-proBNP 与内脏脂肪(β系数=-0.08;p<0.0001)和肝脏脂肪(β系数=-0.14;p<0.0001)呈负相关,与下半身脂肪呈正相关(β系数=0.07;p<0.0001),独立于年龄、性别、种族和肥胖状况;BNP 的结果相似。调整身体成分、稳态模型评估的胰岛素抵抗指数、循环雄激素和脂肪细胞因子并没有减弱这些关联。
更高的利钠肽水平与有利的体脂分布独立相关,表现为内脏脂肪和肝脏脂肪减少,下半身脂肪增加,提示心脏和脂肪组织分布之间存在通过利钠肽介导的联系。